For condition: Hidradenitis Suppurativa
Clinical Trial for Hidradenitis Suppurativa (22 Weeks)
Study Summary
Who Can Participate?
Adults aged 18 to 70 with hidradenitis suppurativa (HS) may be eligible to participate.
Inclusion Criteria
- History of HS for 6 months or longer
- Have at least 5 lesions (abscesses and/or inflammatory nodules) affecting at least 2 different body areas
- Inadequate response to at least one course of antibiotics for the treatment of HS
Participant Information
- Participate and receive study treatment at no cost
- Regular visits with study doctors who specialize in treating HS
- Will receive either an investigative intravenous (IV) infusion treatment (study drug) or a placebo
- Reimbursement for study-related expenses may be provided
How Long Will The Study Last?
- Participation will last about 22 weeks and involve about 9 visits to the study research site.
For more information about this trial, please visit ClinicalTrials.gov
